Macrophage–T Cell Interaction Is Essential for the Induction of p75 Interleukin 2 (IL–2) Receptor and IL–2 Responsiveness in Human CD4+T Cells
- 1 March 1991
- journal article
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 82 (3), 257-261
- https://doi.org/10.1111/j.1349-7006.1991.tb01839.x
Abstract
Fresh human CD8+ T cells showed a strong proliferative response to a high concentration of interleukin 2 (IL–2) in the absence of macrophages. In contrast, CD4+ T cells revealed no significant IL–2 responsiveness in the absence of macrophages. However, if CD4+ T cells were cocultured with macrophages, they showed higher proliferative response to IL–2 than CD8+ T cells. In accordance with the magnitude of IL–2 responsiveness, freshly isolated CD8+ T cells expressed significant amounts of p75 IL–2 receptor, while fresh CD4+ T cells did not express p75 IL–2 receptor. The expression of p75 IL–2 receptor on CD4+ T cells was induced by coculture with macrophages. The macrophage–induced p75 IL–2 receptor acquisition was blocked by monoclonal antibody (inAh) against class II antigen. Moreover, the addition of anti–CD4 mAb or anti–class II mAb to the culture caused a great inhibition of IL–2 responsiveness of CD4+ T cells. These results strongly suggest that macrophage–T cell interaction through CD4 and/or class II molecules is essential for the expression of p75 IL–2 receptor and IL–2 responsiveness in human CD4+, but not CD8+ T cells.Keywords
This publication has 17 references indexed in Scilit:
- Interleukin-1α: Its possible roles in cancer therapyBiotherapy, 1989
- Activation of peripheral blood T cells via the p75 interleukin 2 receptor.The Journal of Experimental Medicine, 1989
- Activation of natural killer cells via the p75 interleukin 2 receptor.The Journal of Experimental Medicine, 1989
- Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.The Journal of Experimental Medicine, 1989
- Characterization of the interleukin 2 receptor beta chain using three distinct monoclonal antibodies.Proceedings of the National Academy of Sciences, 1989
- A new high-yield continuous cell-culture system for lymphokine-activated killer cellsCancer Immunology, Immunotherapy, 1989
- LFA-1 and other accessory molecules functioning in adhesions of T and B lymphocytesHuman Immunology, 1987
- Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.The Journal of Experimental Medicine, 1983
- T‐Cell Growth FactorImmunological Reviews, 1980
- The role of mitogenic lectins in T-cell triggeringNature, 1979